185 related articles for article (PubMed ID: 36208186)
1. Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.
Roseboom IC; Rosing H; Beijnen JH; Dorlo TPC
Biomed Chromatogr; 2023 Jul; 37(7):e5519. PubMed ID: 36208186
[TBL] [Abstract][Full Text] [Related]
2. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Review of Drug-Carrying Nanosystems Used in the Treatment of Leishmaniasis.
Registre C; Soares RDOA; Rubio KTS; Santos ODH; Carneiro SP
ACS Infect Dis; 2023 Mar; 9(3):423-449. PubMed ID: 36795604
[TBL] [Abstract][Full Text] [Related]
4. Leishmaniasis: current status of available drugs and new potential drug targets.
Singh N; Kumar M; Singh RK
Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs.
Kip AE; Schellens JHM; Beijnen JH; Dorlo TPC
Clin Pharmacokinet; 2018 Feb; 57(2):151-176. PubMed ID: 28756612
[TBL] [Abstract][Full Text] [Related]
6. Marine Algae as Source of Novel Antileishmanial Drugs: A Review.
Tchokouaha Yamthe LR; Appiah-Opong R; Tsouh Fokou PV; Tsabang N; Fekam Boyom F; Nyarko AK; Wilson MD
Mar Drugs; 2017 Oct; 15(11):. PubMed ID: 29109372
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue.
Roseboom IC; Thijssen B; Rosing H; Alves F; Younis BM; Musa AM; Beijnen JH; Dorlo TPC
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123494. PubMed ID: 36219923
[TBL] [Abstract][Full Text] [Related]
8. Challenges and new discoveries in the treatment of leishmaniasis.
Singh S; Sivakumar R
J Infect Chemother; 2004 Dec; 10(6):307-15. PubMed ID: 15614453
[TBL] [Abstract][Full Text] [Related]
9. [Current situation and future of antileishmanial therapy in Colombia].
Soto J; Soto P
Biomedica; 2006 Oct; 26 Suppl 1():194-206. PubMed ID: 17361855
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis: advances in treatment.
Maltezou HC
Recent Pat Antiinfect Drug Discov; 2008 Nov; 3(3):192-8. PubMed ID: 18991801
[TBL] [Abstract][Full Text] [Related]
11. Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
Ortega V; Giorgio S; de Paula E
J Liposome Res; 2017 Sep; 27(3):234-248. PubMed ID: 28874072
[TBL] [Abstract][Full Text] [Related]
12. Leishmaniasis: current treatment and prospects for new drugs and vaccines.
Kedzierski L; Sakthianandeswaren A; Curtis JM; Andrews PC; Junk PC; Kedzierska K
Curr Med Chem; 2009; 16(5):599-614. PubMed ID: 19199925
[TBL] [Abstract][Full Text] [Related]
13. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.
Berman JD; Wyler DJ
J Infect Dis; 1980 Jul; 142(1):83-6. PubMed ID: 6249874
[TBL] [Abstract][Full Text] [Related]
14. Current treatment approaches to leishmaniasis.
Berman J
Curr Opin Infect Dis; 2003 Oct; 16(5):397-401. PubMed ID: 14501991
[TBL] [Abstract][Full Text] [Related]
15. Development of new antileishmanial drugs--current knowledge and future prospects.
Le Pape P
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):708-18. PubMed ID: 18671165
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of nicotinamide/antileishmanial drug combinations.
Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance in Indian visceral leishmaniasis.
Sundar S
Trop Med Int Health; 2001 Nov; 6(11):849-54. PubMed ID: 11703838
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
Oliveira LF; Schubach AO; Martins MM; Passos SL; Oliveira RV; Marzochi MC; Andrade CA
Acta Trop; 2011 May; 118(2):87-96. PubMed ID: 21420925
[TBL] [Abstract][Full Text] [Related]
19. Paromomycin in the treatment of leishmaniasis.
Sundar S; Chakravarty J
Expert Opin Investig Drugs; 2008 May; 17(5):787-94. PubMed ID: 18447603
[TBL] [Abstract][Full Text] [Related]
20. Do bismuth complexes hold promise as antileishmanial drugs?
Ong YC; Kedzierski L; Andrews PC
Future Med Chem; 2018 Jul; 10(14):1721-1733. PubMed ID: 29961352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
